Literature DB >> 3934265

Growth and differentiation in vitro of the accumulating Lyt-2-/L3T4- subset in lpr mice.

R C Budd, H R MacDonald, J W Lowenthal, J L Davignon, S Izui, J C Cerottini.   

Abstract

Mice bearing the recessive gene lpr develop an autoimmune syndrome associated with a massive lymphadenopathy, both of which are age and thymus dependent. The predominant accumulating cells in lymphoid tissue of lpr/lpr mice are Thy-1+ but express neither of the mature T cell markers, Lyt-2 or L3T4. We have purified this Lyt-2-/L3T4- subset and examined its phenotype. These cells are not actively cycling, do not express interleukin-2 (IL 2) receptors nor significant levels of antigen receptor, but do express the B cell marker B220. In vitro growth conditions were examined for the lpr Lyt-2-/L3T4- subset. By using a combination of phorbol ester and IL 2, these cells acquired transient expression of IL 2 receptors and grew in an IL 2-dependent manner. Furthermore, these proliferating cells underwent differentiation to a more mature T cell phenotype, with loss of cell surface B220 and acquisition, by a portion, of antigen receptor and Lyt-2. The possible parallels with normal T cell maturation are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3934265

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  IL-2 and IL-4 can co-modulate the generation of cytotoxic T cells through CD8- CD4- splenic lymphocytes.

Authors:  M F Good; L W Powell; J W Halliday
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

2.  Treatment of autoimmune MRL/lpr mice with anti-B220 monoclonal antibody reduces the level of anti-DNA antibodies and lymphadenopathies.

Authors:  V Asensi; K Kimeno; I Kawamura; M Sakumoto; K Nomoto
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

Review 3.  B and T cell antigen receptor repertoires in lupus/arthritis murine models.

Authors:  A N Theofilopoulos; P A Singer; R Kofler; D H Kono; M A Duchosal; R S Balderas
Journal:  Springer Semin Immunopathol       Date:  1989

4.  Subpopulations of CD4+ cells in lpr/lpr mice: differences in expression of T cell receptor/CD3 complex and proliferative responses.

Authors:  T Asano; Y Yoshikai; K Matsumoto; G Matuzaki; K Nomoto
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

5.  In vivo treatment with anti B-220 monoclonal antibody affects T and B cell differentiation.

Authors:  V Asensi; K Himeno; I Kawamura; M Sakumoto; K Nomoto
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

6.  Enhanced and accelerated lymphoproliferation in Fas-null mice.

Authors:  M Adachi; S Suematsu; T Suda; D Watanabe; H Fukuyama; J Ogasawara; T Tanaka; N Yoshida; S Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

7.  Analysis of T cell receptors in rheumatoid arthritis: the increased expression of HLA-DR antigen on circulating gamma delta+ T cells is correlated with disease activity.

Authors:  A Lamour; F Jouen-Beades; O Lees; D Gilbert; X Le Loet; F Tron
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

8.  Development of grafted gld cells in athymic and euthymic recipients.

Authors:  N Rosenblatt; K U Hartmann; F Loor
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

9.  Significant role of Fas ligand-binding but defective Fas receptor (CD95) in lymph node hyperplasia composed of abnormal double-negative T cells.

Authors:  Akio Matsuzawa; Motomu Shimizu; Yasutaka Takeda; Hisashi Nagase; Kazutoshi Sayama; Mikio Kimura
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

10.  Liver is a possible site for the proliferation of abnormal CD3+4-8- double-negative lymphocytes in autoimmune MRL-lpr/lpr mice.

Authors:  T Ohteki; S Seki; T Abo; K Kumagai
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.